Related Experiment Video
Updated: Aug 29, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Prospects for neuroprotection in multiple sclerosis
1Departments of Oncology and Clinical Neurosciences, The University of Calgary, 3330 Hospital Drive N.W., Calgary, Alberta T2N 4N1, Canada. vyong@ucalgary.ca
Abstract:
Axonal injury and neuronal loss are now recognised to be hallmarks of multiple sclerosis (MS) in addition to neuroinflammation and demyelination. This review discusses the factors that contribute to neural degeneration, and it emphasizes the need to confer neuroprotection in MS. The beneficial role of neuroinflammation is highlighted, and the possibility that glatiramer acetate enables neuroprotection in MS through beneficial inflammation is evaluated. Finally, the prospect of an experimental treatment, minocycline, in producing neuroprotection in MS is suggested.
Related Concept Videos
Multiple Sclerosis l: Introduction
The Blood-brain Barrier
Neurogenesis and Regeneration of Nervous Tissue

